VERU INC. Income Taxes Paid
VERU INC. (VERU) reported Income Taxes Paid of $222.22 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2018-12-13
- VERU INC. income taxes paid for the quarter ending 2017-09-30 was $14.81K, a 80.66% decline year-over-year.
- VERU INC. income taxes paid for the quarter ending 2017-06-30 was $52.39K, a 51.52% decline year-over-year.
- VERU INC. income taxes paid for the quarter ending 2017-03-31 was $50.81K, a 48.35% decline year-over-year.
- VERU INC. income taxes paid for the quarter ending 2016-12-31 was $112.69K, a 61.32% increase year-over-year.
- VERU INC. income taxes paid for fiscal 2018 was $222.22K, a 3.68% decline from fiscal 2017.
- VERU INC. income taxes paid for fiscal 2017 was $230.71K, a 34.62% decline from fiscal 2016.
- VERU INC. income taxes paid for fiscal 2016 was $352.86K, a 19.84% increase from fiscal 2015.
- VERU INC. income taxes paid for fiscal 2015 was $294.44K, a 61.91% decline from fiscal 2014.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2018-09-30 | $222.22K 10-K · filed 2018-12-13 | |||
| 2017-09-30 | $14.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $67.20K derived: sum of 2 quarters · filed 2018-12-13 | $118.01K derived: sum of 3 quarters · filed 2018-12-13 | $230.71K 10-K · filed 2018-12-13 |
| 2017-06-30 | $52.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $103.20K derived: sum of 2 quarters · filed 2017-08-09 | $215.89K 10-Q · filed 2017-08-09 | $292.46K derived: sum of 4 quarters · filed 2018-01-02 |
| 2017-03-31 | $50.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $163.50K 10-Q · filed 2017-05-10 | $240.07K derived: sum of 3 quarters · filed 2018-01-02 | $348.14K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-12-31 | $112.69K 10-Q · filed 2017-02-09 | $189.27K derived: sum of 2 quarters · filed 2018-01-02 | $297.33K derived: sum of 3 quarters · filed 2018-01-02 | $395.69K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-09-30 | $76.57K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $184.64K derived: sum of 2 quarters · filed 2018-01-02 | $283.00K derived: sum of 3 quarters · filed 2018-01-02 | $352.86K 10-K · filed 2018-01-02 |
| 2016-06-30 | $108.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $206.43K derived: sum of 2 quarters · filed 2017-08-09 | $276.28K 10-Q · filed 2017-08-09 | $303.33K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-03-31 | $98.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $168.22K 10-Q · filed 2017-05-10 | $195.27K derived: sum of 3 quarters · filed 2018-01-02 | $307.03K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-12-31 | $69.86K 10-Q · filed 2017-02-09 | $96.90K derived: sum of 2 quarters · filed 2018-01-02 | $208.67K derived: sum of 3 quarters · filed 2018-01-02 | $302.87K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-09-30 | $27.05K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $138.81K derived: sum of 2 quarters · filed 2018-01-02 | $233.01K derived: sum of 3 quarters · filed 2018-01-02 | $294.44K 10-K · filed 2018-01-02 |
| 2015-06-30 | $111.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-28 | $205.96K derived: sum of 2 quarters · filed 2016-07-28 | $267.39K 10-Q · filed 2016-07-28 | $459.06K derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | $94.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-28 | $155.63K 10-Q · filed 2016-04-28 | $347.29K derived: sum of 3 quarters · filed 2016-12-12 | $428.04K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $61.43K 10-Q · filed 2016-02-02 | $253.09K derived: sum of 2 quarters · filed 2016-12-12 | $333.84K derived: sum of 3 quarters · filed 2016-12-12 | $393.33K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | $191.66K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $272.41K derived: sum of 2 quarters · filed 2016-12-12 | $331.90K derived: sum of 3 quarters · filed 2016-12-12 | $773.04K 10-K · filed 2016-12-12 |
| 2014-06-30 | $80.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | $140.23K derived: sum of 2 quarters · filed 2015-07-30 | $581.38K 10-Q · filed 2015-07-30 | $719.64K derived: sum of 4 quarters · filed 2015-12-02 |
| 2014-03-31 | $59.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30 | $500.63K 10-Q · filed 2015-04-30 | $638.90K derived: sum of 3 quarters · filed 2015-12-02 | $715.35K derived: sum of 4 quarters · filed 2015-12-02 |
| 2013-12-31 | $441.14K 10-Q · filed 2015-02-03 | $579.41K derived: sum of 2 quarters · filed 2015-12-02 | $655.85K derived: sum of 3 quarters · filed 2015-12-02 | $761.12K derived: sum of 4 quarters · filed 2015-12-02 |
| 2013-09-30 | $138.27K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | $214.71K derived: sum of 2 quarters · filed 2015-12-02 | $319.98K derived: sum of 3 quarters · filed 2015-12-02 | $345.66K 10-K · filed 2015-12-02 |
| 2013-06-30 | $76.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $181.71K derived: sum of 2 quarters · filed 2014-07-31 | $207.39K 10-Q · filed 2014-07-31 | $559.28K derived: sum of 4 quarters · filed 2014-12-02 |
| 2013-03-31 | $105.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $130.95K 10-Q · filed 2014-05-01 | $482.83K derived: sum of 3 quarters · filed 2014-12-02 | |
| 2012-12-31 | $25.68K 10-Q · filed 2014-02-03 | $377.56K derived: sum of 2 quarters · filed 2014-12-02 | ||
| 2012-09-30 | $351.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $926.43K 10-K · filed 2014-12-02 | ||
| 2012-06-30 | $574.55K 10-Q · filed 2013-08-01 | |||
| 2011-09-30 | $57.15K 10-K · filed 2013-12-03 | |||
| 2010-09-30 | $111.93K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |